Equillium logo

Equillium Share Price Today

(NASDAQ: EQ)

Equillium share price is $0.72 & ₹62.62 as on 6 Mar 2025, 2.30 'hrs' IST

$0.72

0.01

(1.41%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Equillium share price in Dollar and Rupees. Guide to invest in Equillium stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Equillium, along with analyst recommendations, forecasts, and comprehensive financials.

Equillium share price movements

  • Today's Low: $0.69
    Today's High: $0.75

    Day's Volatility :7.38%

  • 52 Weeks Low: $0.49
    52 Weeks High: $2.99

    52 Weeks Volatility :83.48%

Equillium (EQ) Returns

PeriodEquillium IncIndex (Russel 2000)
3 Months
4.41%
0.0%
6 Months
-27.55%
0.0%
1 Year
-68.58%
0.0%
3 Years
-79.54%
-11.6%

Equillium (EQ) Key Statistics

in dollars & INR

Previous Close
$0.71
Open
$0.693
Today's High
$0.745
Today's Low
$0.69
Market Capitalization
$26.0M
Today's Volume
$4.3K
52 Week High
$2.985
52 Week Low
$0.493
Revenue TTM
$45.9M
EBITDA
$-6.6M
Earnings Per Share (EPS)
$-0.12
Profit Margin
-10.05%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-19.52%

How to invest in Equillium Stock (EQ) from India?

It is very easy for Indian residents to invest directly in Equillium from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Equillium stock in both Indian Rupees (INR) and US Dollars (USD). Search for Equillium or EQ on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Equillium or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Equillium shares which would translate to 1.208 fractional shares of Equillium as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Equillium, in just a few clicks!

Returns in Equillium (EQ) for Indian investors in Rupees

The Equillium stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Equillium investment value today

Current value as on today

₹36,821

Returns

₹63,179

(-63.18%)

Returns from Equillium Stock

₹68,142 (-68.14%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Equillium (EQ)

5%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Equillium Stock from India on INDmoney has increased by 5% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Equillium

  • Decheng Capital LLC

    12.55%

  • Vanguard Group Inc

    2.38%

  • Cota Capital Management, LLC

    1.59%

  • Renaissance Technologies Corp

    0.74%

  • Geode Capital Management, LLC

    0.58%

  • Callan Capital, LLC

    0.28%

Analyst Recommendation on Equillium

Buy

    91%Buy

    8%Hold

    0%Sell

Based on 12 Wall street analysts offering stock ratings for Equillium(by analysts ranked 0 to 5 stars)

Based on 12 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
11
11
11
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Equillium Stock (EQ)

What analysts predicted

Upside of 316.67%

Target:

$3.00

Current:

$0.72

Insights on Equillium Stock (Ticker Symbol: EQ)

  • Price Movement

    In the last 1 year, EQ stock has moved down by -68.3%
  • EQ vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 130.6%
  • EQ vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 127.3%
  • Price to Sales

    ForEQ every $1 of sales, investors are willing to pay $0.5, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $13.8 for every $1 of sales.

Equillium Technicals Summary

Sell

Neutral

Buy

Equillium is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Equillium (EQ) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Equillium Inc logo
6.77%
-27.55%
-68.58%
-79.54%
-83.29%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Equillium Inc logo
NA
NA
NA
-0.37
-0.2
-0.09
NA
0.65
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Equillium Inc logo
Buy
$26.0M
-83.29%
NA
-10.05%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Equillium

Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a first-in-class monoclonal antibody that targets the immune checkpoint receptor CD6, which is in Phase III clinical trials for the treatment of acute graft-versus-host disease; completed Phase I clinical trial for the treatment of ulcerative colitis; and Phase I clinical trial for the treatment of lupus nephritis. It also develops EQ101 completed phase 1/2 for treatment of cutaneous T cell lymphoma and alopecia areata; and EQ302 to treat gastrointestinal indications. In addition, it serves dermatology, gastroenterology, rheumatology, hematology, transplant science, oncology, and pulmonology area. Equillium, Inc. has a research collaboration agreement with Vivtex Corporation to develop GI-targeted formulations for Bi-specific peptide therapy. The company was formerly known as Attenuate Biopharmaceuticals, Inc. and changed its name to Equillium, Inc. in May 2017. Equillium, Inc. was incorporated in 2017 and is headquartered in La Jolla, California.
Organization
Equillium
Employees
45
CEO
Mr. Bruce D. Steel C.F.A.
Industry
Health Technology

Management People of Equillium

NameTitle
Mr. Daniel Mark Bradbury
Executive Chairman
Mr. Bruce D. Steel C.F.A.
Co-Founder, President, CEO & Director
Ms. Christine Zedelmayer M.B.A., P.M.P.
Senior VP & COO
Dr. Stephen Connelly Ph.D.
Chief Scientific Officer & Director
Mr. Jason A. Keyes
Chief Financial Officer
Penny Tom
Senior VP of Finance & Principal Accounting Officer
Mr. Michael Moore
Vice President of Investor Relations & Corporate Communications
Dr. Matthew Ritter Ph.D.
Senior Vice President of Corporate Development
Mr. Joel M. Rothman
Chief Development Officer

Important FAQs about investing in EQ Stock from India :

What is Equillium share price today?

Equillium share price today stands at $0.72, Open: $0.69 ; Previous Close: $0.71 ; High: $0.75 ; Low: $0.69 ; 52 Week High: $2.99 ; 52 Week Low: $0.49.

The stock opens at $0.69, after a previous close of $0.71. The stock reached a daily high of $0.75 and a low of $0.69, with a 52-week high of $2.99 and a 52-week low of $0.49.

Can Indians buy Equillium shares?

Yes, Indians can invest in the Equillium (EQ) from India.

With INDmoney, you can buy Equillium at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Equillium at zero transaction cost.

How can I buy Equillium shares from India?

It is very easy to buy Equillium from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Equillium (EQ) be purchased?

Yes, you can buy fractional shares of Equillium with INDmoney app.

What are the documents required to start investing in Equillium stocks?

To start investing in Equillium, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Equillium Stock (EQ)?

Today’s highest price of Equillium (EQ) is $0.75.

Today’s lowest price of Equillium (EQ) is $0.69.

What is today's market capitalisation of Equillium?

Today's market capitalisation of Equillium EQ is 26.0M

What is the 52 Week High and Low Range of Equillium Stock (EQ)?

  • 52 Week High

    $2.99

  • 52 Week Low

    $0.49

What are the historical returns of Equillium (EQ)?

  • 1 Month Returns

    6.77%

  • 3 Months Returns

    -27.55%

  • 1 Year Returns

    -68.58%

  • 5 Years Returns

    -83.29%

Who is the Chief Executive Officer (CEO) of Equillium ?

Mr. Bruce D. Steel C.F.A. is the current Chief Executive Officer (CEO) of Equillium.